Big Pharma Chasing Obesity Drug Boom
Michael Shah, Senior Equity Research Analyst, Bloomberg Intelligence
18-Jan-24 07:30
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
The chronic weight management market is at an inflection point. Analysts have forecast that sales of weight-loss drugs could potentially hit 100 billion US dollars by 2030, buoyed by promising results in recent clinical trials. We speak to Michael Shah, Senior Equity Research Analyst at Bloomberg Intelligence for insights into this growing market.
Image credit: Shutterstock.com
Produced by: Chin Wai Lun
Presented by: Shazana Mokhtar, Wong Shou Ning, Keith Kam
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: technology, medical advances
Tags: weight loss drugs, pharmaceutical companies medical trials, big pharma, clinical trials,
